title: Progestins: pro-senescence therapy for ovarian cancer?
authors.affiliation: Womens Cancer Research Center, University of Pittsburgh Cancer Institute and Magee-Womens Research Institute; University of Pittsburgh, Pittsburgh, PA USA. oesterreichs@upmc.edu
authors.forename: Steffi
authors.initials: S
authors.lastname: Oesterreich
authors.forename: Robert
authors.initials: R
authors.lastname: Edwards
authors.forename: Anda
authors.initials: A
authors.lastname: Vlad
mesh_terms: D016922:Cellular Senescence; D005260:Female; D051858:Forkhead Transcription Factors / Q000378:metabolism*; D006801:Humans; D010051:Ovarian Neoplasms / Q000378:metabolism* / Q000473:pathology*; D011980:Receptors, Progesterone / Q000378:metabolism*
chemical_list: D051858:Forkhead Transcription Factors; D011980:Receptors, Progesterone
keywords: FOXO1; immune therapy; ovarian cancer; progesterone; senescence